SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 167.29 |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 78.94 |
| Book Value / Share | 0.75 |
| Price / Book | n/a |
| NCAV ($M) | 65.33 |
| NCAV / Share | 0.62 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.32 |
| Return on Assets (ROA) | -0.24 |
| Return on Equity (ROE) | -0.87 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 4.10 |
| Current Ratio | 4.10 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 138.08 |
| Assets | 151.69 |
| Liabilities | 72.75 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 19.55 |
| Operating Income | -30.47 |
| Net Income | -27.76 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -36.39 |
| Cash from Investing | -4.07 |
| Cash from Financing | 70.28 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Adage Capital Management, L.P. | 7.70 | -15.62 | |
| 13G/A | Van Herk Investments B.v. | 10.90 | 40.29 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 46,447 | 342,425 | 13.56 | |
| 85,915 | 320,463 | 26.81 | |
| 81,777 | 433,400 | 18.87 | |
| 87,320 | 344,693 | 25.33 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| PRFX – PainReform Ltd. | PROK – ProKidney Corp. |
| PRPH – ProPhase Labs, Inc. | PRTG – Portage Biotech Inc. |
| PTIX – Protagenic Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io